Skip to main content
. 2018 Aug 21;97(35):e12007. doi: 10.1097/MD.0000000000012007

Figure 4.

Figure 4

The combined value of miR-20a, miR-17-5p, miR-18a, miR-19b-1, miR-19a, and miR-92-1 for predicting disease progression (A) and chemotherapy efficiency (B) in patients with advanced gastric cancer.